Prediction of survival in patients suspected of disseminated intravascular coagulation

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 7, 2015, Pages 870-880

  Hjorleifsson, E ^a   Sigurdsson, M I ^b,c   Gudmundsdottir, B R ^b   Sigurdsson, G H ^a,b   Onundarson, P T ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN; D DIMER; FIBRINOGEN; PROTEIN C;

ADULT; ARTICLE; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FOLLOW UP; HUMAN; ISTH SCORE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SCORING SYSTEM; SURVIVAL; TERTIARY CARE CENTER; THROMBOCYTE COUNT; COHORT ANALYSIS; EPIDEMIOLOGY; ICELAND; PROGNOSIS; RETROSPECTIVE STUDY; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

ADULT; COHORT STUDIES; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; ICELAND; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84937023162     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12537     Document Type: Article

References (28)

1. Levi M, Ten Cate H,. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
2. Levi M, van der Poll T,. Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med 2013; 8: 23-32.
3. Bick RL, Arun B, Frenkel EP,. Disseminated intravascular coagulation. clinical and pathophysiological mechanisms and manifestations. Haemostasis 1999; 29: 111-34.
4. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M,. Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
5. Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H,. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol 1999; 60: 273-8.
6. Okamoto K, Wada H, Hatada T, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Asakura H, Koga S, Iba T, Maruyama I,. Japanese Society of Thrombosis Hemostasis DICs. Frequency and hemostatic abnormalities in pre-DIC patients. Thromb Res 2010; 126: 74-8.
7. Levi M, Meijers JC,. DIC: which laboratory tests are most useful. Blood Rev 2011; 25: 33-7.
8. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P,. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-23.
9. Okabayashi K, Wada H, Ohta S, Shiku H, Nobori T, Maruyama K,. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol 2004; 76: 225-9.
10. Bakhtiari K, Meijers JC, de Jonge E, Levi M,. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-21.
11. Lee JH, Song J,. Diagnosis of non-overt disseminated intravascular coagulation made according to the International Society on Thrombosis and Hemostasis criteria with some modifications. Korean J Hematol 2010; 45: 260-3.
12. Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, Morishita E, Yamazaki M, Suga Y, Miyamoto KI, Nakao S,. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2001; 12: 275-81.
13. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H,. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group. Thromb Haemost 1995; 74: 848-52.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
15. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative w. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
16. Zavada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA, investigators AKI,. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant 2010; 25: 3911-8.
17. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R,. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
18. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M,. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004; 2: 1924-33.
19. Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ, ten Cate JW,. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.
20. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP,. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000; 96: 3719-24.
21. Asakura H, Wada H, Okamoto K, Iba T, Uchiyama T, Eguchi Y, Kawasugi K, Koga S, Mayumi T, Koike K, Gando S,. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 2006; 95: 282-7.
22. Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S,. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 2001; 29: 1164-8.
23. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T,. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 2003; 72: 1-7.
24. Oh D, Jang MJ, Lee SJ, Chong SY, Kang MS, Wada H,. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis. Thromb Res 2010; 126: 18-23.
25. Toh CH, Downey C,. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2005; 16: 69-74.
26. Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, Shiraishi SI, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N,. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013; 17: R111.
27. Angstwurm MW, Dempfle CE, Spannagl M,. New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 2006; 34: 314-20; quiz 28.
28. Sadler JE,. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.